跳至主要内容
临床试验/NCT00452296
NCT00452296Unknown不适用

Tight Glycemic Control in Acute Exacerbations of COPD

Soroka University Medical Center0 个研究点目标入组 84 人开始时间: 2007年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
84
主要终点
mortality

研究概览

简要总结

Glucose control has been shown as an important and independent prognostic factor in several acute conditions in hospitalized patients, including Acute MI, stroke, cardiac surgery and in critical care units.

Patients with acute exacerbation of COPD (AECOPD)and diabetes treated with insulin had a longer in-patient stay and more frequent isolation of Gram negative bacteria from sputum than those without diabetes.Hyperglycemia (>11 mmol/l) on admission predicted failure of non-invasive ventilation and infectious pulmonary complications in patients admitted to the ICU with acute respiratory failure caused by severe AECOPD.

The primary goal of this study is to test the hypothesis that in AECOPD, tight glycemic control during hospital stay will improve outcome of hospitalization.

The secondary goal of this study is to test new ways in controlling patients in the internal medicine ward.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
45 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • current or past smokers (at least 20 py)
  • patient with COPD be ATS criteria
  • hospitalized with acute exacerbation, 2/3 criteria:1- worsening of SOB 2-change in sputum volume 3- change in sputum color
  • signed informed concent

排除标准

  • respiratory failure (pH<7.35 ו Pco2>60 )
  • pneumonia
  • pneumothorax
  • bronchiectasis
  • lung collapse
  • congestive heart failure
  • lung cancer
  • suspected pulmonary emboli
  • immune deficiency (acquired 0r congenital)
  • cystic fibrosis
  • post lung implantation
  • asthma/ non smokers

结局指标

主要结局

mortality

时间窗: one year

次要结局

  • hospialization(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Idit F Liberty

Dr Idit Liberty MD

Soroka University Medical Center

相似试验